We design, perform and interpret high resolution proteomics studies to improve target discovery, validation and mechanism of action studies.
Combined tissue and fluid proteomics delivers superior discovery and validation of diagnostic, stratification and pharmacodynamic biomakers.
For Clinical Trial Samples – Scientist.com recently qualified our SRM and TMT-SRM assays as being fit-for-purpose under GCLP accreditation.
Published in the July edition of EBR magazine - Proteome Sciences plc Mass Spectrometry Based Proteomics Read more
New report on growing opportunities for TMT: “Tandem Mass Tag Usage Could Benefit From New Methods, Expanded Applications” available to premium subscribers of GenomeWeb Link here
Landmark paper on Alzheimer's disease molecular pathology published Read more